XBIT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

XBiotech Inc

NASDAQ | XBIT

2.58

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$77.44M

Market Cap

-

P/E Ratio

-0.91

EPS

$8.32

52 Week High

$2.50

52 Week Low

HEALTHCARE

Sector

XBIT Chart

Recent Chart
Price Action

XBIT Technicals

Tags:

XBIT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue $1.7M
Costof Goods And Services Sold $1.7M
Operating Income -$42M
Selling General And Administrative $4.7M
Research And Development $38M
Operating Expenses $42M
Investment Income Net -
Net Interest Income $9M
Interest Income $9.8M
Interest Expense $807K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.7M
Income Before Tax -$39M
Income Tax Expense -$32K
Interest And Debt Expense -
Net Income From Continuing Operations -$39M
Comprehensive Income Net Of Tax -
Ebit -$38M
Ebitda -$36M
Net Income -$39M

Revenue & Profitability

Earnings Performance

XBIT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $199M
Total Current Assets $175M
Cash And Cash Equivalents At Carrying Value $173M
Cash And Short Term Investments $173M
Inventory -
Current Net Receivables $858K
Total Non Current Assets $25M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1M
Other Non Current Assets -
Total Liabilities $17M
Total Current Liabilities $15M
Current Accounts Payable $2.2M
Deferred Revenue -
Current Debt -
Short Term Debt $10M
Total Non Current Liabilities $1.7M
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt $10M
Long Term Debt Noncurrent -
Short Long Term Debt Total $10M
Other Current Liabilities $912K
Other Non Current Liabilities -
Total Shareholder Equity $182M
Treasury Stock -
Retained Earnings -$91M
Common Stock $273M
Common Stock Shares Outstanding $30M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$31M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.7M
Capital Expenditures $1.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.3M
Cashflow From Financing $10M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$39M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue $1.7M
Costof Goods And Services Sold $1.7M
Operating Income -$42M
Selling General And Administrative $4.7M
Research And Development $38M
Operating Expenses $42M
Investment Income Net -
Net Interest Income $9M
Interest Income $9.8M
Interest Expense $807K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.7M
Income Before Tax -$39M
Income Tax Expense -$32K
Interest And Debt Expense -
Net Income From Continuing Operations -$39M
Comprehensive Income Net Of Tax -
Ebit -$38M
Ebitda -$36M
Net Income -$39M

Dividends

Field Value
Ex Dividend Date 2021-07-15
Declaration Date None
Record Date None
Payment Date None
Amount 2.5

XBIT News

XBIT Profile

XBiotech Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

XBiotech Inc. is a biopharmaceutical company based in Austin, Texas, specializing in the discovery and development of True Human monoclonal antibodies aimed at treating a wide range of diseases. With a focus on innovative therapies, XBiotech is committed to advancing its pipeline of monoclonal antibodies, which have the potential to revolutionize patient care across multiple therapeutic areas. The company's unique platform leverages human immune cells to generate antibodies, thereby enhancing efficacy and safety in treatment options.

VHAI
-25.00%
$0.00
YYAI
-14.74%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+5.36%
$0.50
ELBM
+272.00%
$6.13
PLUG
+10.38%
$3.77
GWH
+170.12%
$11.23
BYND
-46.77%
$1.06
BITF
+23.72%
$5.19
NVDA
+2.99%
$188.64
ASST
-29.09%
$1.10
RGTI
+17.89%
$51.78
SNAP
-7.15%
$7.78
IONZ
-29.05%
$2.41
AXDX
-61.36%
$0.03
DNN
+6.42%
$3.06
NVTS
+22.35%
$10.06
GPUS
-9.16%
$0.43
INTC
+2.21%
$37.17
CAN
+27.44%
$1.38
MP
+8.36%
$78.34
PWM
+12.50%
$1.17
QS
+17.68%
$17.30
NIO
+6.70%
$7.16
QBTS
+18.50%
$39.13
CRML
+42.25%
$21.31
F
+1.05%
$11.53
TLRY
-1.73%
$1.69
TSLA
+3.25%
$426.95
JOBY
+4.29%
$16.98
RMBL
+60.50%
$3.21
SOUN
+9.27%
$18.97
ADD
-25.47%
$0.05
LAES
+11.73%
$6.04
BBD
+1.47%
$3.10
CIFR
+16.14%
$19.71
USAR
+20.65%
$39.34
AMD
+2.20%
$219.64
ETHD
-8.24%
$3.50
ABAT
+37.13%
$9.25
HPE
-7.04%
$24.40
APLD
+8.20%
$36.78
SRM
+53.27%
$10.30
ONDS
+20.11%
$11.07
RXRX
+1.03%
$5.37
INTS
-3.97%
$0.30
UUUU
+18.68%
$24.14
DVLT
-7.63%
$1.75
EOSE
+21.59%
$16.80
EPWK
-10.88%
$0.08
NAK
+19.00%
$2.41
ACHR
+5.47%
$12.62
SOFI
+2.55%
$26.85
RR
+10.38%
$6.53
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NOK
-1.50%
$5.24
CLF
+5.19%
$13.86
NEHC
-8.12%
$2.60
DFLI
+24.58%
$1.35
WLGS
-5.57%
$0.04
IREN
+10.78%
$66.21
PFE
+0.12%
$24.81
AVGO
+10.50%
$358.74
AAL
+1.87%
$11.73
BTBT
+2.32%
$3.84
KDLY
-7.21%
$0.87
GDXD
-13.41%
$0.73
QUBT
+11.12%
$21.13
ADAP
+3.83%
$0.19
UAMY
+30.87%
$15.98
AMC
+0.68%
$2.95
PLTR
+0.66%
$176.61
ETWO
0.00%
$3.30
NB
+3.56%
$10.76
NAKA
-1.14%
$0.86
MARA
+9.16%
$20.36
BULL
+0.30%
$11.43
PMAX
+74.19%
$4.51
WULF
+4.66%
$14.14
BMNR
+3.59%
$54.35
RIG
+2.59%
$3.16
AFMD
-34.94%
$0.18
CLSK
+0.98%
$19.47
AMZN
+1.92%
$220.53
TMQ
+12.11%
$6.64
NAMM
+27.21%
$4.01
SMR
+15.72%
$45.41
IONQ
+13.69%
$80.32
QSI
+22.03%
$2.03
TMC
+17.38%
$10.43
OPI
-16.97%
$0.20
AAPL
+1.49%
$248.93
HOOD
-0.10%
$138.81
KLG
-9.05%
$13.35
GRYP
-10.38%
$1.38
OKLO
+14.55%
$168.58
VHAI
-25.00%
$0.00
YYAI
-14.74%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+5.36%
$0.50
ELBM
+272.00%
$6.13
PLUG
+10.38%
$3.77
GWH
+170.12%
$11.23
BYND
-46.77%
$1.06
BITF
+23.72%
$5.19
NVDA
+2.99%
$188.64
ASST
-29.09%
$1.10
RGTI
+17.89%
$51.78
SNAP
-7.15%
$7.78
IONZ
-29.05%
$2.41
AXDX
-61.36%
$0.03
DNN
+6.42%
$3.06
NVTS
+22.35%
$10.06
GPUS
-9.16%
$0.43
INTC
+2.21%
$37.17
CAN
+27.44%
$1.38
MP
+8.36%
$78.34
PWM
+12.50%
$1.17
QS
+17.68%
$17.30
NIO
+6.70%
$7.16
QBTS
+18.50%
$39.13
CRML
+42.25%
$21.31
F
+1.05%
$11.53
TLRY
-1.73%
$1.69
TSLA
+3.25%
$426.95
JOBY
+4.29%
$16.98
RMBL
+60.50%
$3.21
SOUN
+9.27%
$18.97
ADD
-25.47%
$0.05
LAES
+11.73%
$6.04
BBD
+1.47%
$3.10
CIFR
+16.14%
$19.71
USAR
+20.65%
$39.34
AMD
+2.20%
$219.64
ETHD
-8.24%
$3.50
ABAT
+37.13%
$9.25
HPE
-7.04%
$24.40
APLD
+8.20%
$36.78
SRM
+53.27%
$10.30
ONDS
+20.11%
$11.07
RXRX
+1.03%
$5.37
INTS
-3.97%
$0.30
UUUU
+18.68%
$24.14
DVLT
-7.63%
$1.75
EOSE
+21.59%
$16.80
EPWK
-10.88%
$0.08
NAK
+19.00%
$2.41
ACHR
+5.47%
$12.62
SOFI
+2.55%
$26.85
RR
+10.38%
$6.53
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NOK
-1.50%
$5.24
CLF
+5.19%
$13.86
NEHC
-8.12%
$2.60
DFLI
+24.58%
$1.35
WLGS
-5.57%
$0.04
IREN
+10.78%
$66.21
PFE
+0.12%
$24.81
AVGO
+10.50%
$358.74
AAL
+1.87%
$11.73
BTBT
+2.32%
$3.84
KDLY
-7.21%
$0.87
GDXD
-13.41%
$0.73
QUBT
+11.12%
$21.13
ADAP
+3.83%
$0.19
UAMY
+30.87%
$15.98
AMC
+0.68%
$2.95
PLTR
+0.66%
$176.61
ETWO
0.00%
$3.30
NB
+3.56%
$10.76
NAKA
-1.14%
$0.86
MARA
+9.16%
$20.36
BULL
+0.30%
$11.43
PMAX
+74.19%
$4.51
WULF
+4.66%
$14.14
BMNR
+3.59%
$54.35
RIG
+2.59%
$3.16
AFMD
-34.94%
$0.18
CLSK
+0.98%
$19.47
AMZN
+1.92%
$220.53
TMQ
+12.11%
$6.64
NAMM
+27.21%
$4.01
SMR
+15.72%
$45.41
IONQ
+13.69%
$80.32
QSI
+22.03%
$2.03
TMC
+17.38%
$10.43
OPI
-16.97%
$0.20
AAPL
+1.49%
$248.93
HOOD
-0.10%
$138.81
KLG
-9.05%
$13.35
GRYP
-10.38%
$1.38
OKLO
+14.55%
$168.58
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.